Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Illingworth

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
British Journal of Rheumatology|September 1, 1993
Abnormal fibrinolysis in chronic low back painK Illingworth, M I Jayson
The Journal of Rheumatology|August 1, 1993
Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenonA D Blann, K Illingworth, M I Jayson
British Journal of Rheumatology|October 1, 1987
Ibuprofen does not affect fibrinolytic activityP Klimiuk, K Illingworth, A Keegan, et al.
Annals of the Rheumatic Diseases|January 1, 1991
A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosisM I Jayson, C D Holland, A Keegan, et al.
Annals of the Rheumatic Diseases|November 1, 1994
Plasma TGF beta in systemic sclerosis: a cross-sectional studyN Snowden, B Coupes, A Herrick, et al.
Annals of the Rheumatic Diseases|February 1, 1996
Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosisA L Herrick, K Illingworth, A Blann, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
British Journal of Rheumatology|September 1, 1993
Abnormal fibrinolysis in chronic low back painK Illingworth, M I Jayson
The Journal of Rheumatology|August 1, 1993
Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenonA D Blann, K Illingworth, M I Jayson
British Journal of Rheumatology|October 1, 1987
Ibuprofen does not affect fibrinolytic activityP Klimiuk, K Illingworth, A Keegan, et al.
Annals of the Rheumatic Diseases|January 1, 1991
A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosisM I Jayson, C D Holland, A Keegan, et al.
Annals of the Rheumatic Diseases|November 1, 1994
Plasma TGF beta in systemic sclerosis: a cross-sectional studyN Snowden, B Coupes, A Herrick, et al.
Annals of the Rheumatic Diseases|February 1, 1996
Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosisA L Herrick, K Illingworth, A Blann, et al.
Pageof 1